具代表性研究發表

搜尋類別: 關鍵字搜尋: 清除
年度 論文名稱
2026 Liu Y, (Ma C)*, The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins., Advances in experimental medicine and biology, vol. 1491, 447-473, 2026
2026 Diyapoglu A., Liu YY, Abay A, Lin KH, Lo IW, Chang CF, Huang YP, Chung CT, Li TL*, Meng MH*, The Crucial Role of LTTR_0390 in Burkholderia gladioli BBB-01 in Orchestrating Antibiotic Production, Quorum-Sensing Responses, and Pathogenicity on Mushrooms, JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 74, 12, 1-14, 2026
2026 Zhongshan He*, Yaoyao Luo, Shuping Yang, Haixing Shi, Ya-Chih Huang, Zhuoming Zhou, Shengbin Liu, Wanqin Zeng, Wei-Chieh Liu, Yongjiang Li, Yuting Chen, Duotian Qin, Xing Duan, Xi He, Wei Chen*, Xiangrong Song*, Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis, ACS Nano, vol. 20, 8350-8371, 2026
2026 Grace Y. T. Tan, Pei-Yi Lin, Li-Tzu Cheng, Yu-Sheng Tsai Yuan, Shih-Han Huang, Chen-Hsin Albert Yu, Chao-Tsen Chen, Peter Chi, (Wendy W. Hwang-Verslues)*, BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC), EMBO MOLECULAR MEDICINE, 2026
2026 Huang Shu-Yu, Shih Orion, Jeng U-Ser, (Chang Chi-Fon, Lin Jung-Hsin, Malliavin Thérèse E., pH Sensitivity of the SERF1a Conformational Ensemble, ACS Omega, vol. 11(2), 2614-2627, 2026
2026 Chou, T.-F., Chiu, H.-C., Gebreyesus, S., Chen, G.-F., Chen, Y.-J., Velasquez, A. R., (Lin, K.-I, Chen, Y.-J., Tu, H.-L., MiProChip: A Scalable Microfluidic Platform for Multiplexed Single-cell Proteomics via Isobaric Labeling, Analytical Chemistry, vol. 98(9):, 6874-6886, 2026
2026 Tseng TC, Hosaka T, (Yang HI, Chen CJ, Kao JH, Reply: HBV DNA level of genuine immune-tolerant patients., HEPATOLOGY, vol. 83(3), E110-E111, 2026
2026 Lin YS, Lin YC, Chen YY, Chen YM, Chen IC, Tsai HJ, Chen CC, Lee SW, (Yang HI*, Lee TY*, Liver Steatosis-Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. doi: 10.1111/apt.70566, doi: 10.1111/apt.70566, 2026
2026 Liu XR, Yang TH, Su TH, Yin SC, Chen YT, Chen FF, Pang ST, Hou MC, Peng YC, Yang SF, Huang PJ, Lee SL, Chen M, Huang CY, Chang YH, Chen HY, (Yang HI, Yu ML, Chen CJ, Kao JH, Lee MH, Genome-wide association study identifies three PNPLA3/SAMM50 SNPs associated with HCC development in non-viral liver disease., JHEP REPORTS, vol. 8(2), 101673, 2026
2026 Yi-Hong Cai, Yi-Sheng Wang*, Theoretical Study of High-Order Velocity Focusing Achieved with Single-Stage Reflectron Time-of-flight Mass Spectrometry, Journal of the American Society for Mass Spectrometry, vol. 37 (1), 33-41, 2026
2026 Zhang T, Huang CJ, Chen HT, Huang YH, Pan MH, Lee MH, Viard M, Hildesheim A, Pfeiffer RM, Carrington M, Chen CJ, Zhu B, Lenz TL, Jiang D*, (Yang HI*, Liu Z, HLA-DQB1*03:01 and risk of Hepatitis B virus-related hepatocellular carcinoma., HEPATOLOGY, vol. 83 (2), 374-386, 2026
2026 Tseng TC, Hosaka T, Pan MH, Liu CJ, Suzuki F, Chen CJ, Su TH, Kumada H, Yang WT, Yang HC, Liu CH, Chen PJ, (Yang HI*, Kao JH*, Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patients., HEPATOLOGY, vol. 83 (1), 142-155, 2026
2025 Hu CM, Tien SC, Lo YC, Huang CH, Ko YL, Wu DN, Lee JH, Wu YT, (Yu HM, Lin KG, Zong-You L, Cheng WC, Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy., Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 184, 117892, 2025
2025 Hu CM, Tien SC, Lo YC, Huang CH, Ko YL, Wu DN, Lee JH, (Wu YT, Yu HM, Lin KG, Zong-You L, Cheng WC, Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy., Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 184, 117892, 2025
2025 Lo JM, Kung CC, (Cheng TR, Wong CH, Ma C, Structure-Based Mechanism and Specificity of Human Galactosyltransferase beta3GalT5., Journal of the American Chemical Society, vol. 147(13), 10875-10885, 2025
2025 Chang YC, Hsieh ML, Lee HL, Hee SW, Chang CF, Yen HY, Chen YA, Chen YR, Chou YW, Li FA, Ke YY, Chen SY, Hung MS, Hung AF, Huang JY, Chiu CH, Lin SY, Shih SF, Hsu CN, Hwang JJ, Yeh TK, (Cheng TR, Liao KC, Laio D, Lin SW, Chen TY, Hu CM, Vogel U, Saar D, Kragelund BB, Tsou LK, Tseng YH, Chuang LM, Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity., EMBO molecular medicine, vol. 17(5), 938-966, 2025
2025 Wu DN, Fajiculay E, Hsu CP, (Hu CM, Lee LW, Tzou DM, Investigation of pH-dependent (1)H NMR urine metabolite profiles for diagnosis of obesity-related disordering., International journal of obesity, vol. 49(4), 688-697, 2025
2025 Hu CM, Tien SC, Lo YC, Huang CH, Ko YL, Wu DN, Lee JH, Wu YT, Yu HM, Lin KG, Zong-You L, (Cheng WC*, Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy., Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 184, 117892, 2025
2025 Liao KS, Zhou Y, Chung C, Kung CC, (Ren CT, Wu CY, Lou YW, Chuang PK, Imre B, Hsieh YSY, Wong CH*, Chemical and Enzymatic Synthesis of DisialylGb5 and Other Sialosides for Glycan Array Assembly and Evaluation of Siglec-Mediated Immune Checkpoint Inhibition., Molecules (Basel, Switzerland), vol. 30(11), 2025
2025 Chan MH*, Zhuang RE, Wei DH*, (Hsiao M, Biomimetic red blood cell membrane-coated FePt metal-organic framework nanoparticles: a multifunctional theranostic system for enhanced MRI and targeted therapy., Nanoscale, vol. 17(40), 23343-23353, 2025
2025 Chuang PK, Chung C, Liao KS, (Wong CH)*, Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade., Proceedings of the National Academy of Sciences of the United States of America, vol. 122(38), e2517415122, 2025
2025 Lin KY, Jiang JK, Lai JI, Lin SY, Ku YC, Lin MH, Yang CY, Lo LC, (Hsu TL, Chang YC*, Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer., NPJ precision oncology, vol. 9(1), 398, 2025
2025 Bagheri N, Margvelani G, Chiang TW, Nelson PT, (Chuang TJ, Stamm S*, Circular RNAs from the MAPT and TARDBP genes: Novel players in neurodegeneration?, Neurochemistry international, vol. 189, 106019, 2025
2025 Hong MX, Wang BW, Lo LH, Jayalath GED, Lin WT, Yang YL, Tseng SP, Chen YH, Tsai WC, (Cheng WC, Liaw CC*, Pseudopeptides of Marine Vibrio spp. from Taiwan and Their Combined Treatment Effects with Commercial Antibiotics., Planta medica, vol. 91(6-07), 371-381, 2025
2025 Wang CP*, Yu KJ, Chen TC, Tsai MS, Kang CJ, Chien CY, Engels EA, Hua CH, Hsu WL, Chang YL, Dawsey SM, Wentzensen N, Shi J, Mao F, Cheung LC, Katki HA, Boyd E, Wu CT, Gutkind JS, Molinolo A, Limbach AL, Lingen MW, Lou PJ, (Chen CJ, Hildesheim A, Chaturvedi AK, Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan., Oral oncology, vol. 162, 107210, 2025
2025 Liu CH, Yang ST, Chao WT, Lin CH, Lee YC, Lai CR, (Hsieh SL, Wang LW, Wang PH*, Targeting the ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti-VEGF resistance in endometrial cancer., International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, vol. 171(3), 1343-1354, 2025
2025 Liao TL*, Chen DY, (Hsieh SL, Yang YY, Chen YM, Tang KT, Chang CH, Yang SS, Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesicles., Hepatology (Baltimore, Md.), vol. 82(3), 722-738, 2025
2025 Peng HY, Chang CW, Wu PH, Li LJ, Lin YL, (Hsiao M, Chang JY, Chang PM, Lee HL*, Chang WM*, Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression., International journal of molecular sciences, vol. 26(3), 1077, 2025
2025 Chung SY, Yeh YC, Huang CJ, Chiang NJ, Hsu DS, Chan MH, Lu ML, Hsu TS, Hung YP, Yeh CN, (Hsiao M, Chang YC, Wang YC, Chen MH*, Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma., Journal for immunotherapy of cancer, vol. 13(1), e010173, 2025
2025 Shimabukuro J, Shen CH, Hsueh TK, Chen TW, Tseng YC, Gannedi V, Dumalaog JS, Chang CH*, (Cheng TR)*, Yu CS*, Hung SC*, Streamlined Synthesis and Immunomodulatory Effects of Ulvan Oligosaccharides from Marine Green Algae., Journal of the American Chemical Society, vol. 147(36), 32951-32962, 2025